| ID Source | ID |
|---|---|
| PubMed CID | 3081171 |
| MeSH ID | M0197161 |
| Synonym |
|---|
| 118674-04-7 |
| sulfo-dst |
| 3-pyrrolidinesulfonic acid, 1,1'-((2,3-dihydroxy-1,4-butanediyl)bis(oxy))bis(2,5-dioxo- |
| bis(sulfosuccinimidyl)tartrate |
| 1-[4-(2,5-dioxo-3-sulfopyrrolidin-1-yl)oxy-2,3-dihydroxy-4-oxobutanoyl]oxy-2,5-dioxopyrrolidine-3-sulfonic acid |
| FT-0625350 |
| disulfosuccinimidyl tartrate |
| disulphosuccinimidyl tartrate |
| DTXSID50922748 |
| 1,1'-[(2,3-dihydroxy-1,4-dioxobutane-1,4-diyl)bis(oxy)]bis(2,5-dioxopyrrolidine-3-sulfonic acid) |
| 1,1'-((2,3-dihydroxysuccinyl)bis(oxy))bis(2,5-dioxopyrrolidine-3-sulfonic acid) |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.42) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||